3D Bioprinted Skin: How the Chanel and Labskin Creations Launch Works

• 1
  Why Chanel and Labskin Creations Printed Skin
• 2
  How Extrusion Bioprinting Builds a Skin Model
• 3
  Bioinks, Cells and the Support Problem
• 4
  Vascular Channels and the Diffusion Limit
• 5
  Where Repeatability Breaks Down on 3D Bioprinted Skin
• 6
  The Machine Side: Motion, Syringes and Fixtures
• 7
  Printed Skin Models Against Other Test Methods

In February 2023, Chanel and Labskin Creations announced a collaboration around 3D bioprinted skin. The stated goal was a laboratory skin model that carries pigment-producing melanocytes and can be used to test skincare formulations. Cosmetics companies already grow flat cell cultures in dishes. A printed construct adds depth and structure.

The reason is simple. A flat monolayer of keratinocytes behaves nothing like a 0.5–1.5 mm thick epidermis sitting on a dermis. Distance from the surface changes how a formula diffuses, where it accumulates, and how long it stays active. A printed model lets formulators measure those effects instead of guessing.

Pigmentation matters just as much. Spots and uneven tone are driven by melanocytes sitting in the basal layer, not on top of it. To study a brightening serum you need those cells in the right position relative to the keratinocytes above them. Positional control is a printing problem, not a biology problem.

• 1
  Depth mattersDiffusion distance changes how actives behave.
• 2
  Position mattersMelanocytes must sit in the basal layer.
• 3
  Repeatability mattersBatch-to-batch variation ruins comparisons.

Most skin bioprinters use extrusion. A syringe or cartridge holds a bioink made of hydrogel and living cells, and a nozzle lays it down in continuous strands. A typical nozzle runs 200–500 μm in diameter, and a finished strand sits 150–400 μm wide once it relaxes on the bed.

The construct is built layer by layer, usually 6 to 20 layers depending on the target thickness. A dermal layer goes down first, loaded with fibroblasts in a collagen or fibrin matrix. Then a basal layer carries melanocytes, and finally keratinocytes are deposited on top. Some systems print the epidermis as a separate sheet and place it after maturation.

After printing, the construct goes into an incubator at 37 °C with 5% CO₂. The hydrogel crosslinks, cells attach, and the layers fuse over 3–14 days. Air-liquid interface culture is often used at the end so the top surface can keratinize, which is what gives the model a real barrier.

• 1
  Nozzle size200–500 μm typical extrusion diameter.
• 2
  Layer count6–20 layers for a 0.5–1.5 mm construct.
• 3
  Maturation3–14 days at 37 °C, 5% CO₂.

A bioink has to do two jobs that pull against each other. It must flow through a nozzle without killing cells, and it must hold shape once deposited. Shear stress at the nozzle wall is the main killer. Above roughly 10–20 kPa of extrusion pressure, viability drops fast, so the hydrogel is usually kept soft.

Collagen type I, fibrin, alginate, gelatin methacryloyl and hyaluronic acid blends are the common bases. Collagen gives the best cell attachment but gels slowly and shrinks. Alginate prints cleanly and crosslinks with calcium ions, but cells cannot remodel it. Many groups blend the two and accept a compromise.

Soft hydrogels sag. That is why printed skin usually needs support, either a sacrificial gelatin or Pluronic bath, a dissolvable scaffold, or printed channels that later become vessels. Without support, a 1 mm wall will slump within minutes and the layer registration is lost.

• 1
  Keep shear lowSoft gels, short nozzles, moderate pressure.
• 2
  Blend for balanceCollagen for biology, alginate for shape.
• 3
  Plan supportSacrificial baths stop sagging.

Here is the hard physical wall. Cells beyond about 200 μm from a blood supply die. In native skin, capillaries sit 100–200 μm apart and everything is fed. A printed construct with no vessels can only survive as a thin sheet, which is fine for a test model and useless for a graft.

Printing channels solves part of it. A 200–400 μm channel network embedded in the dermal layer lets medium perfuse the interior, and endothelial cells seeded into those channels can line them. Perfusion is usually started slowly, 0.1–1 mL/min, to avoid washing the soft matrix away.

Even with channels, printed skin is not a substitute for a full-thickness graft. It is thin, mechanically weak, and has no hair follicles, sweat glands or nerve endings. Those structures come from developmental signaling that no current printer reproduces. The value is in testing, not in replacement.

• 1
  200 μm ruleCells farther than this from supply die.
• 2
  Channel size200–400 μm, perfused at 0.1–1 mL/min.
• 3
  Missing partsNo follicles, glands or nerves.

A printed skin batch is only useful if batch 2 matches batch 1. In practice, three variables drift. Cell passage number changes how fast cells proliferate, so a model made at passage 4 behaves differently from one at passage 8. Hydrogel lot-to-lot variation changes stiffness by tens of percent. And room temperature on the print bed changes how fast the strand gels.

Printing parameters have the same problem. A 10 °C shift in bioink temperature changes viscosity enough to alter strand width by 20–30%. If the operator does not log temperature, pressure and speed together, the data from that plate is hard to trust.

This is the same discipline that runs a machine shop. Fix the inputs, record them, and inspect the output. For a printed skin model, the measurable outputs are layer thickness, cell viability, barrier function and pigment response. If any of those drifts more than about 15% between batches, the model is not ready for comparative testing.

• 1
  Log everythingTemperature, pressure, speed, passage number.
• 2
  Watch viscosity10 °C shifts strand width 20–30%.
• 3
  Set a drift limitAbove ~15% variation, results are unusable.

A bioprinter is a motion system with a heated syringe holder. Most units run three axes with a 10–50 μm positioning resolution, well inside the 150–400 μm strand width, so the motion stage is rarely the limiting factor. The syringe and nozzle are.

Nozzle concentricity and cartridge seating decide whether the strand lands where the toolpath says. A 50 μm lateral runout at the tip shows up as a wandering wall in a 12-layer construct. Tapered tips with a smooth internal bore reduce both shear and clogging compared with blunt needles.

Temperature control at the nozzle is the other weak point. Bioink should sit at 4–25 °C before printing and crosslink at 37 °C after. A holder that swings 5 °C during a run changes flow rate mid-print. Machined aluminum holders with a Peltier stage hold ±1 °C and cost little to make, which is why they show up in most custom rigs.

Machine shops get asked for these parts constantly: syringe adapters, nozzle holders, print-bed plates, perfusion manifolds and sterilization trays. They are small, toleranced, and usually needed in tens rather than thousands.

• 1
  Motion is fine10–50 μm resolution beats the strand width.
• 2
  Tooling is notRunout at the tip shows up in the wall.
• 3
  Hold ±1 °CMachined holders with Peltier control.